Gaining a foothold: How HIV avoids innate immune recognition

Current Opinion in Immunology

Volumn 23, Issue 1, 2011, Pages 21-28

  Yan, Nan ^a   Lieberman, Judy ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TREX1; UNCLASSIFIED DRUG; VIRUS DNA;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MUTATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS GENOME; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; RNA, VIRAL;

EID: 79951680545     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.11.004     Document Type: Review

References (89)

1. Shattock R.J., Moore J.P. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003, 1:25-34.
2. Haase A.T. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005, 5:783-792.
3. Margolis L., Shattock R. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?. Nat Rev Microbiol 2006, 4:312-317.
4. Hladik F., McElrath M.J. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008, 8:447-457.
5. Keele B.F., Derdeyn C.A. Genetic and antigenic features of the transmitted virus. Curr Opin HIV AIDS 2009, 4:352-357.
6. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464:217-223.
7. Pope M., Haase A.T. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003, 9:847-852.
8. Zhang L.Q., MacKenzie P., Cleland A., Holmes E.C., Brown A.J., Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993, 67:3345-3356.
9. Zhu T., Wang N., Carr A., Nam D.S., Moor-Jankowski R., Cooper D.A., Ho D.D. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996, 70:3098-3107.
10. Zhang Z., Schuler T., Zupancic M., Wietgrefe S., Staskus K.A., Reimann K.A., Reinhart T.A., Rogan M., Cavert W., Miller C.J., et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999, 286:1353-1357.
11. Derdeyn C.A., Decker J.M., Bibollet-Ruche F., Mokili J.L., Muldoon M., Denham S.A., Heil M.L., Kasolo F., Musonda R., Hahn B.H., et al. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004, 303:2019-2022.
12. Abrahams M.R., Anderson J.A., Giorgi E.E., Seoighe C., Mlisana K., Ping L.H., Athreya G.S., Treurnicht F.K., Keele B.F., Wood N., et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J Virol 2009, 83:3556-3567.
13. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 2008, 105:7552-7557.
14. Miller C.J., Alexander N.J., Vogel P., Anderson J., Marx P.A. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol 1992, 21:64-68.
15. Lu Y., Brosio P., Lafaile M., Li J., Collman R.G., Sodroski J., Miller C.J. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J Virol 1996, 70:3045-3050.
16. Marx P.A., Spira A.I., Gettie A., Dailey P.J., Veazey R.S., Lackner A.A., Mahoney C.J., Miller C.J., Claypool L.E., Ho D.D., et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996, 2:1084-1089.
17. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., Ho D.D. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996, 183:215-225.
18. Trichel A.M., Roberts E.D., Wilson L.A., Martin L.N., Ruprecht R.M., Murphey-Corb M. SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque. J Med Primatol 1997, 26:3-10.
19. Harouse J.M., Tan R.C., Gettie A., Dailey P., Marx P.A., Luciw P.A., Cheng-Mayer C. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques. Virology 1998, 248:95-107.
20. Sodora D.L., Gettie A., Miller C.J., Marx P.A. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses 1998, 14(Suppl 1):S119-123.
21. Harouse J.M., Gettie A., Eshetu T., Tan R.C., Bohm R., Blanchard J., Baskin G., Cheng-Mayer C. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol 2001, 75:1990-1995.
22. Miller C.J., Li Q., Abel K., Kim E.Y., Ma Z.M., Wietgrefe S., La Franco-Scheuch L., Compton L., Duan L., Shore M.D., et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005, 79:9217-9227.
23. Abel K., Rocke D.M., Chohan B., Fritts L., Miller C.J. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol 2005, 79:12164-12172.
24. Li Q., Estes J.D., Schlievert P.M., Duan L., Brosnahan A.J., Southern P.J., Reilly C.S., Peterson M.L., Schultz-Darken N., Brunner K.G., et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458:1034-1038.
25. Romano G., Guan M., Long W.K., Henderson E.E. Efficient virus transmission from dendritic cells to CD4+ T cells in response to antigen depends on close contact through adhesion molecules. Virology 1997, 239:259-268.
26. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
27. Nobile C., Petit C., Moris A., Skrabal K., Abastado J.P., Mammano F., Schwartz O. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J Virol 2005, 79:5386-5399.
28. Arrighi J.F., Pion M., Garcia E., Escola J.M., van Kooyk Y., Geijtenbeek T.B., Piguet V. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med 2004, 200:1279-1288.
29. de Witte L., Nabatov A., Pion M., Fluitsma D., de Jong M.A., de Gruijl T., Piguet V., van Kooyk Y., Geijtenbeek T.B. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007, 13:367-371.
30. Fahrbach K.M., Barry S.M., Ayehunie S., Lamore S., Klausner M., Hope T.J. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol 2007, 81:6858-6868.
31. de Jong M.A., de Witte L., Oudhoff M.J., Gringhuis S.I., Gallay P., Geijtenbeek T.B. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 2008, 118:3440-3452.
32. de Jong M.A., Geijtenbeek T.B. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players. J Intern Med 2009, 265:18-28.
33. Goldfeld A.E., Birch-Limberger K., Schooley R.T., Walker B.D. HIV-1 infection does not induce tumor necrosis factor-alpha or interferon-beta gene transcription. J Acquir Immune Defic Syndr 1991, 4:41-47.
34. Rodrigo Mora J., Von Andrian U.H. Specificity and plasticity of memory lymphocyte migration. Curr Top Microbiol Immunol 2006, 308:83-116.
35. Mora J.R., von Andrian U.H. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol 2006, 27:235-243.
36. Sigmundsdottir H., Butcher E.C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 2008, 9:981-987.
37. Campbell D.J., Butcher E.C. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med 2002, 195:135-141.
38. Mora J.R., Bono M.R., Manjunath N., Weninger W., Cavanagh L.L., Rosemblatt M., Von Andrian U.H. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003, 424:88-93.
39. Dieu-Nosjean M.C., Massacrier C., Homey B., Vanbervliet B., Pin J.J., Vicari A., Lebecque S., Dezutter-Dambuyant C., Schmitt D., Zlotnik A., et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000, 192:705-718.
40. Dieu-Nosjean M.C., Vicari A., Lebecque S., Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leukoc Biol 1999, 66:252-262.
41. Caux C., Ait-Yahia S., Chemin K., de Bouteiller O., Dieu-Nosjean M.C., Homey B., Massacrier C., Vanbervliet B., Zlotnik A., Vicari A. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 2000, 22:345-369.
42. Narimatsu R., Wolday D., Patterson B.K. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 2005, 21:228-233.
43. Shoemaker C., Hoffman J., Goff S., Baltimore D. Intramolecular integration within Moloney murine leukemia virus DNA. J Virol 1981, 40:164-172.
44. Li Y., Kappes J., Conway J., Price R., Shaw G., Hahn B. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol 1991, 65:3973-3985.
45. Garfinkel D., Stefanisko K., Nyswaner K., Moore S., Oh J., Hughes S. Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap. J Virol 2006, 80:11920-11934.
46. Li L., Farnet C., Anderson W., Bushman F. Modulation of activity of Moloney murine leukemia virus preintegration complexes by host factors in vitro. J Virol 1998, 72:2125-2131.
47. Lee M., Craigie R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc Natl Acad Sci U S A 1998, 95:1528-1533.
48. Smed-Sörensen A., Loré K., Vasudevan J., Louder M.K., Andersson J., Mascola J.R., Spetz A.-L., Koup R.A. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 2005, 79:8861-8869.
49. McIlroy D., Autran B., Cheynier R., Wain-Hobson S., Clauvel J.P., Oksenhendler E., Debré P., Hosmalin A. Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol 1995, 69:4737-4745.
50. Beignon A.-S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., Larsson M., Gorelick R.J., Lifson J.D., Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005, 115:3265-3275.
51. Yan N., Regalado-Magdos A.D., Stiggelbout B., Lee-Kirsch M.A., Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 2010, 11:1005-1013.
52. Yan N., Cherepanov P., Daigle J.E., Engelman A., Lieberman J. The SET complex acts as a barrier to autointegration of HIV-1. PLoS Pathog 2009, 5:e1000327.
53. Bowerman B., Brown N., Bishop K., Varmus H. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev 1989, 3:469-478.
54. Miller M., Farnet C., Bushman F. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 1997, 71:5382-5390.
55. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., Sirois C.M., Jin T., Latz E., Xiao T.S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11:997-1004.
56. Yanai H., Ban T., Wang Z., Choi M.K., Kawamura T., Negishi H., Nakasato M., Lu Y., Hangai S., Koshiba R., et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009, 462:99-103.
57. Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009, 10:1065-1072.
58. Chiu Y.-H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
59. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
60. Hornung V., Latz E. Intracellular DNA recognition. Nat Rev Immunol 2010, 10:123-130.
61. Hoss M., Robins P., Naven T., Pappin D., Sgouros J., Lindahl T. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J 1999, 18:3868-3875.
62. Mazur D., Perrino F. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3′→5′ exonucleases. J Biol Chem 1999, 274:19655-19660.
63. Morita M., Stamp G., Robins P., Dulic A., Rosewell I., Hrivnak G., Daly G., Lindahl T., Barnes D. Gene-targeted mice lacking the Trex1 (DNase III) 3′→5′ DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 2004, 24:6719-6727.
64. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
65. Yang Y., Lindahl T., Barnes D. Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease. Cell 2007, 131:873-886.
66. Crow Y., Hayward B., Parmar R., Robins P., Leitch A., Ali M., Black D., van Bokhoven H., Brunner H., Hamel B., et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 2006, 38:917-920.
67. Crow Y.J., Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009, 18:R130-136.
68. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.-A., de Silva U., Bailey S.L., Witte T., Vyse T.J., et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007, 39:1065-1067.
69. Lee-Kirsch M.A., Chowdhury D., Harvey S., Gong M., Senenko L., Engel K., Pfeiffer C., Hollis T., Gahr M., Perrino F.W., et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med 2007, 85:531-537.
70. Zandman-Goddard G., Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002, 1:329-337.
71. Yasutomo K., Horiuchi T., Kagami S., Tsukamoto H., Hashimura C., Urushihara M., Kuroda Y. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001, 28:313-314.
72. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., Möröy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000, 25:177-181.
73. Yoshida H., Okabe Y., Kawane K., Fukuyama H., Nagata S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 2005, 6:49-56.
74. Chowdhury D., Beresford P., Zhu P., Zhang D., Sung J., Demple B., Perrino F., Lieberman J. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 2006, 23:133-142.
75. Chowdhury D., Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 2008, 26:389-420.
76. Liu Z., Jang S.W., Liu X., Cheng D., Peng J., Yepes M., Li X.J., Matthews S., Watts C., Asano M., et al. Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol Cell 2008, 29:665-678.
77. Manel N., Hogstad B., Wang Y., Levy D.E., Unutmaz D., Littman D.R. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010, 467:214-217.
78. Goujon C., Jarrosson-Wuillème L., Bernaud J., Rigal D., Darlix J.-L., Cimarelli A. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther 2006, 13:991-994.
79. Luban J., Bossolt K., Franke E., Kalpana G., Goff S. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73:1067-1078.
80. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
81. Stremlau M., Owens C., Perron M., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
82. Song B. TRIM5alpha. Curr Top Microbiol Immunol 2009, 339:47-66.
83. Doehle B., Hladik F., McNevin J., McElrath M., Gale M. HIV-1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol 2009.
84. Carrington M., Martin M.P., van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol 2008, 16:620-627.
85. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., Colombo S., Brown E.E., Shupert W.L., Phair J., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007, 39:733-740.
86. Lehmann C., Harper J.M., Taubert D., Hartmann P., Fatkenheuer G., Jung N., van Lunzen J., Stellbrink H.J., Gallo R.C., Romerio F. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients. J Acquir Immune Defic Syndr 2008, 48:522-530.
87. Trinchieri G: Type I interferon: friend or foe? J Exp Med 2010, 207:2053-2063.
88. Gringhuis S.I., van der Vlist M., van den Berg L.M., den Dunnen J., Litjens M., Geijtenbeek T.B. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 2010, 11:419-426.
89. Tavel JA, Huang CY, Shen J, Metcalf JA, Dewar R, Shah A, Vasudevachari MB, Follmann DA, Herpin B, Davey RT, et al.: Interferon-alpha produces significant decreases in HIV load. J Interferon Cytokine Res 2010, 30:461-464.